SNCA and Parkinson disease: For example, in PD, where a progressive dopamine decline due to a degeneration of the SNPC occurs, generally visual hallucinations are experienced at a later stage of disease (i.e. when abnormal alpha-synuclein accumulation at the cortical and retinal levels is marked) or immediately after the introduction of dopamine agonists, in a dose-dependent fashion [13].